Mac McKeen, MBA, RAC
Fellow, Regulatory Science
Boston Scientific Corporation
FDA has had the pre-sub meeting process in place for several years and they just finalized the latest guidance in May of this year. This solution circle will discuss strategies for when and how to best utilize this process throughout the Total Product Life Cycle of the product and process. Spoiler Alert! It is not always just about product development and the clinical trial.